InvestmentJun 24, 2026, 04:07 PM
Indaptus Therapeutics Raises $12M in Private Placement
AI Summary
Indaptus Therapeutics, Inc. entered into a Stock Purchase Agreement on June 17, 2026, to sell 20,000,000 shares of its common stock at $0.60 per share in a private placement. This transaction generated approximately $12,000,000 in gross proceeds for the company. The shares were sold to certain non-U.S. accredited investors, and the company is required to file a registration statement for the resale of these shares within 90 days.
Key Highlights
- Indaptus Therapeutics raised approximately $12,000,000 in gross proceeds.
- The company sold 20,000,000 shares of common stock at $0.60 per share.
- Shares were issued to certain non-U.S. accredited investors.
- The private placement was conducted directly by the company with no commissions.
- Company must file a registration statement for resale within 90 days of closing.
- The shares were issued under exemptions from registration via Section 4(a)(2) and Regulation S.
Price Impact
More from INDP